Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name SNHG1
   Synonyms SNHG1, LINC00057, NCRNA00057, U22HG, UHG, lncRNA16
   Region GRCh38_11:62851988-62855914    Sequence
   Ensembl ENSG00000255717
   RefSeq NR_003098
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name lung cancer
   ICD-0-3 C35  
   Methods qPCR etc.
   Sample blood
   Expression Pattern differential expression
   Function Description

The panels of three miRNAs (miRs-21, 210, and 486-5p), two lncRNAs (SNHG1 and RMRP), and two FUTs (FUT8 and POFUT1) have a sensitivity of 81-86% and a specificity of 84-87% for diagnosis of lung cancer. From the seven genes, an integromic plasma signature comprising miR-210, SNHG1, and FUT8 is developed that produces higher sensitivity (95.45%) and specificity (96.97%) compared with the individual biomarker panels (all p<0.05).

   Pubmed ID 29872497
   Year 2018
   Title An integromic signature for lung cancer early detection.
   External Links
   Links for  SNHG1 GenBank       HGNC       lncrnadb       Noncode
   Links for  lung cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.